Development and evaluation of a lymph node invasion risk prediction model in intermediate- and high-risk prostate cancer patients
The Oslo model enhances predictive performance in intermediate- and high-risk patients using easily accessible clinical and MRI data, potentially reducing unnecessary PLND interventions and assisting clinicians in treatment decision-making.
Authors
- Håkon Ramberg (ORCID: https://orcid.org/0000-0002-5434-6029)
- Francesco Barletta (ORCID: https://orcid.org/0000-0003-3585-3217)
- Tord Hompland (ORCID: https://orcid.org/0000-0003-0529-6077)
- Knut Håkon Hole (ORCID: https://orcid.org/0000-0001-6885-8538)
- Viktor Berge (ORCID: https://orcid.org/0000-0003-3349-5794)
- Petter Davik
- Tone F. Bathen (ORCID: https://orcid.org/0000-0002-8582-6965)
- Giorgio Gandaglia
- Manuela Zucknick (ORCID: https://orcid.org/0000-0003-1317-7422)
- Shivanthe Sivanesan (ORCID: https://orcid.org/0000-0003-2089-2248)
- Kristin Austlid Taskén (ORCID: https://orcid.org/0000-0001-5530-4915)
- Alberto Briganti
- Lars Magne Eri
- Stian Ole Prestbakk
- Åsmund Nybøen
Institutions
- Oslo University Hospital (NO)
- Vita-Salute San Raffaele University (IT)
- University of Oslo (NO)
- Norwegian University of Science and Technology (NO)
- St Olav's University Hospital (NO)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
Publication Details
- Journal
- Acta Oncologica
- Published
- 2025-10-22
- DOI
- https://doi.org/10.2340/1651-226x.2025.43970
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universitetet i Oslo